(Q38474516)

English

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial

scientific article published on 15 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

phase I clinical trial

0 references

0 references

0 references

author name string

Yan-Ping Li

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Zheng-Lun Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Qiang Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Li-Rong Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Qun-Ying Mao

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Shu-Qun Wen

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yan Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Wei-Dong Yin

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Rong-Cheng Li

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jun-Zhi Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

15 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3295-3303

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

An apparently new enterovirus isolated from patients with disease of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Genetic evolution of enterovirus 71: epidemiological and pathological implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Enterovirus 71 outbreak, Brunei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Enterovirus 71 vaccine: close but still far.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Neutralizing antibodies to enterovirus 71 in Belém, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA) in adults: safety, tolerability, and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Seroepidemiology of human enterovirus 71, Singapore

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Risk Factors of Enterovirus 71 Infection and Associated Hand, Foot, and Mouth Disease/Herpangina in Children During an Epidemic in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.010

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.03.010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38474516&oldid=1761355492"